• FDA OKs Anti-BCMA Drug for Multiple Myeloma

    1 month ago - By MedPageToday

    The FDA granted accelerated approval to belantamab mafodotin on Wednesday in heavily pretreated multiple myeloma.
    Belantamab mafodotin is the first approved therapy that targets B-cell maturation antigen , and...
    Read more ...

     

  • FDA Approves Belantamab in R/R Multiple Myeloma

    FDA Approves Belantamab in R/R Multiple Myeloma

    1 month ago - By Medscape

    The first-in-class drug belantamab mafodotin has been approved in the United States for use in relapsed and refractory multiple myeloma.
    FDA Approvals
    Read more ...